Skip to content

Influence of Bushen Tiaojing Series Prescriptions on Assisted Reproductive Pregnancy Outcomes in Patients with Kidney Deficiency and Infertility

Influence of Bushen Tiaojing Series Prescriptions on Assisted Reproductive Pregnancy Outcomes in Patients with Kidney Deficiency and Infertility

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005490
Enrollment
Unknown
Registered
2021-12-31
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Treatment group:Chinese Medicine + Western Medicine

Sponsors

Hebei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of infertility and the criteria of TCM syndrome differentiation; (2) Age = 35 years; (3) No organic disease in the reproductive tract; (4) Bilateral fallopian tubes are not unblocked; (5) The man's semen examination is normal; (6) Receiving IVF-ET or intracytoplasmic sperm injection-embryo transfer to assist pregnancy; (7) Voluntary trial, treatment and follow-up after conception.

Exclusion criteria

Exclusion criteria: (1) Does not meet the diagnostic criteria of infertility and TCM syndrome differentiation criteria; (2) Age> 35 years old; (3) Organic diseases such as genital malformations, congenital gonadal hypoplasia, and uterine amenorrhea; (4) 3 months Those who are treated with hormone drugs; (5) Endometriosis, endometrial polyps, intrauterine adhesions, etc.; (6) Combined with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; ( 7) Premature ovarian failure caused by removal of both ovaries or unilateral ovaries.

Design outcomes

Primary

MeasureTime frame
Total gonadotropins;estradiol;number of oocytes obtained;TCM Evidence Score;embryos obtained;

Countries

China

Contacts

Public Contactliuxueping
965782894@qq.com15100083589

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026